{"entity":{"type":"insider","cik":"0001778713","url":"/insider/0001778713","json_url":"/insider/0001778713.json","name":"Cadavid Diego","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":10,"first":"2020-02-05","last":"2022-02-14","span_basis":"filed_date"},"name_variants":[{"name":"Cadavid Diego","source":"filing","n_filings":10,"first_seen":"2020-02-05","last_seen":"2022-02-14"}],"transactions":[{"id":6161905,"accession":"0001628280-22-002505","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-002505","line_url":"/filing/0001628280-22-002505#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001778713","owner_name":"Cadavid Diego","owner_display_name":"Cadavid Diego","owner_url":"/insider/0001778713","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":928.0,"shares_display":"928","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":7107.0,"shares_owned_after_display":"7,107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-11","filed_date":"2022-02-14","scope":"insider"},{"id":2133033,"accession":"0000899243-20-018278","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-018278","line_url":"/filing/0000899243-20-018278#line-1","is_derivative":false,"issuer_cik":"0001680581","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001680581","owner_cik":"0001778713","owner_name":"Cadavid Diego","owner_display_name":"Cadavid Diego","owner_url":"/insider/0001778713","role":"Officer (SVP Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1071.0,"shares_display":"1,071","price_per_share":18.3,"price_display":"18.30","price_state":"stated","total_value":19599.3,"total_display":"19,599.30","total_whole":"19,599","shares_owned_after":65714.0,"shares_owned_after_display":"65,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-02","scope":"insider"},{"id":2773082,"accession":"0000899243-20-017761","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-017761","line_url":"/filing/0000899243-20-017761#line-2","is_derivative":false,"issuer_cik":"0001680581","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001680581","owner_cik":"0001778713","owner_name":"Cadavid Diego","owner_display_name":"Cadavid Diego","owner_url":"/insider/0001778713","role":"Officer (SVP Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1459.0,"shares_display":"1,459","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":32098.0,"total_display":"32,098.00","total_whole":"32,098","shares_owned_after":66785.0,"shares_owned_after_display":"66,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-25","filed_date":"2020-06-26","scope":"insider"},{"id":2244951,"accession":"0000899243-20-016382","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-016382","line_url":"/filing/0000899243-20-016382#line-2","is_derivative":false,"issuer_cik":"0001680581","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001680581","owner_cik":"0001778713","owner_name":"Cadavid Diego","owner_display_name":"Cadavid Diego","owner_url":"/insider/0001778713","role":"Officer (SVP Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":401.0,"shares_display":"401","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":8822.0,"total_display":"8,822.00","total_whole":"8,822","shares_owned_after":66785.0,"shares_owned_after_display":"66,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-10","filed_date":"2020-06-12","scope":"insider"},{"id":3161578,"accession":"0000899243-20-015623","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-015623","line_url":"/filing/0000899243-20-015623#line-4","is_derivative":false,"issuer_cik":"0001680581","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001680581","owner_cik":"0001778713","owner_name":"Cadavid Diego","owner_display_name":"Cadavid Diego","owner_url":"/insider/0001778713","role":"Officer (SVP Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":451.0,"shares_display":"451","price_per_share":20.1791,"price_display":"20.18","price_state":"stated","total_value":9100.7741,"total_display":"9,100.77","total_whole":"9,101","shares_owned_after":66785.0,"shares_owned_after_display":"66,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-05","filed_date":"2020-06-08","scope":"insider"},{"id":3161567,"accession":"0000899243-20-015623","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-015623","line_url":"/filing/0000899243-20-015623#line-2","is_derivative":false,"issuer_cik":"0001680581","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001680581","owner_cik":"0001778713","owner_name":"Cadavid Diego","owner_display_name":"Cadavid Diego","owner_url":"/insider/0001778713","role":"Officer (SVP Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":226.0,"shares_display":"226","price_per_share":20.0498,"price_display":"20.05","price_state":"stated","total_value":4531.2548,"total_display":"4,531.25","total_whole":"4,531","shares_owned_after":66785.0,"shares_owned_after_display":"66,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-04","filed_date":"2020-06-08","scope":"insider"},{"id":3074710,"accession":"0000899243-20-015245","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-015245","line_url":"/filing/0000899243-20-015245#line-4","is_derivative":false,"issuer_cik":"0001680581","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001680581","owner_cik":"0001778713","owner_name":"Cadavid Diego","owner_display_name":"Cadavid Diego","owner_url":"/insider/0001778713","role":"Officer (SVP Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":338.0,"shares_display":"338","price_per_share":20.1763,"price_display":"20.18","price_state":"stated","total_value":6819.5894,"total_display":"6,819.59","total_whole":"6,820","shares_owned_after":66785.0,"shares_owned_after_display":"66,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-03","filed_date":"2020-06-04","scope":"insider"},{"id":3074699,"accession":"0000899243-20-015245","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-015245","line_url":"/filing/0000899243-20-015245#line-2","is_derivative":false,"issuer_cik":"0001680581","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001680581","owner_cik":"0001778713","owner_name":"Cadavid Diego","owner_display_name":"Cadavid Diego","owner_url":"/insider/0001778713","role":"Officer (SVP Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45.0,"shares_display":"45","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":900.0,"total_display":"900.00","total_whole":"900","shares_owned_after":66785.0,"shares_owned_after_display":"66,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-02","filed_date":"2020-06-04","scope":"insider"},{"id":2726326,"accession":"0000899243-20-014722","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-014722","line_url":"/filing/0000899243-20-014722#line-4","is_derivative":false,"issuer_cik":"0001680581","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001680581","owner_cik":"0001778713","owner_name":"Cadavid Diego","owner_display_name":"Cadavid Diego","owner_url":"/insider/0001778713","role":"Officer (SVP Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":20.035,"price_display":"20.04","price_state":"stated","total_value":4007.0,"total_display":"4,007.00","total_whole":"4,007","shares_owned_after":66785.0,"shares_owned_after_display":"66,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-29","filed_date":"2020-06-01","scope":"insider"},{"id":2726318,"accession":"0000899243-20-014722","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-014722","line_url":"/filing/0000899243-20-014722#line-2","is_derivative":false,"issuer_cik":"0001680581","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001680581","owner_cik":"0001778713","owner_name":"Cadavid Diego","owner_display_name":"Cadavid Diego","owner_url":"/insider/0001778713","role":"Officer (SVP Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":12000.0,"total_display":"12,000.00","total_whole":"12,000","shares_owned_after":66785.0,"shares_owned_after_display":"66,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-28","filed_date":"2020-06-01","scope":"insider"},{"id":2132694,"accession":"0000899243-20-012822","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-012822","line_url":"/filing/0000899243-20-012822#line-2","is_derivative":false,"issuer_cik":"0001680581","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001680581","owner_cik":"0001778713","owner_name":"Cadavid Diego","owner_display_name":"Cadavid Diego","owner_url":"/insider/0001778713","role":"Officer (SVP Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1860.0,"shares_display":"1,860","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":33480.0,"total_display":"33,480.00","total_whole":"33,480","shares_owned_after":66785.0,"shares_owned_after_display":"66,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-12","filed_date":"2020-05-12","scope":"insider"},{"id":2856936,"accession":"0000899243-20-006590","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-006590","line_url":"/filing/0000899243-20-006590","is_derivative":false,"issuer_cik":"0001680581","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001680581","owner_cik":"0001778713","owner_name":"Cadavid Diego","owner_display_name":"Cadavid Diego","owner_url":"/insider/0001778713","role":"Officer (SVP Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2143.0,"shares_display":"2,143","price_per_share":17.38440508632758,"price_display":"17.38","price_state":"stated","total_value":37254.7801,"total_display":"37,254.78","total_whole":"37,255","shares_owned_after":67100.0,"shares_owned_after_display":"67,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-02","scope":"insider","n_lines":2},{"id":2771937,"accession":"0000899243-20-003272","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-003272","line_url":"/filing/0000899243-20-003272#line-1","is_derivative":false,"issuer_cik":"0001680581","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001680581","owner_cik":"0001778713","owner_name":"Cadavid Diego","owner_display_name":"Cadavid Diego","owner_url":"/insider/0001778713","role":"Officer (SVP Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2143.0,"shares_display":"2,143","price_per_share":17.3317,"price_display":"17.33","price_state":"stated","total_value":37141.8331,"total_display":"37,141.83","total_whole":"37,142","shares_owned_after":68928.0,"shares_owned_after_display":"68,928","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-03","filed_date":"2020-02-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001501697","name":"X4 Pharmaceuticals, Inc","url":"/issuer/0001501697","role":"Officer (Chief Medical Officer)","n_filings":1,"first_seen":"2022-02-14","last_seen":"2022-02-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001680581","name":"Fulcrum Therapeutics, Inc.","url":"/issuer/0001680581","role":"Officer (SVP Clinical Development)","n_filings":9,"first_seen":"2020-02-05","last_seen":"2020-07-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001778713","retrieved_at":"2026-08-22T23:20:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}